Envenomation by the red-tailed coral snake (Micrurus mipartitus) in Colombia
© The Author(s). 2017
Received: 21 September 2016
Accepted: 4 February 2017
Published: 14 February 2017
Although the red-tailed coral snake (Micrurus mipartitus) is widely distributed in Colombia and its venom is highly neurotoxic and life threatening, envenomation by this species is rare. Therefore, this report may shed some light on the clinical presentation of M. mipartitus bites.
Herein, we describe two cases of patients bitten by red-tailed coral snakes, illustrating the clinical presentation of the victims, the outcomes and treatment provided.
Envenomation caused by M. mipartitus provokes predicable neurotoxicity, and its treatment should be based on respiratory support and use of specific antivenom.
Envenomation caused by snake venoms remains a neglected public health problem in most tropical countries. A better understanding of the venoms and clinical aspects of snakebites facilitates the prevention and management of the victims [1, 2]. Colombia has a rich fauna of reptiles, particularly venomous snakes. The red-tailed coral snake Micrurus mipartitus is a member of the Elapidae family that is found in Panamá, Colombia, Ecuador and Venezuela. Despite its broad distribution in Colombia, envenomation is rare. About 0.4% of reported cases of envenomation by ophidians in the country are due to coral snakes . Possible causes for this include low notification of cases, the evasive behavior of the snake and the small size of its mouth (with little proteroglyphous fangs).
Timid, nocturnal and mostly subterranean, this M. mipartitus tends to hide under weed, fallen leaves and grasses. It is oviparous and its venom is neurotoxic, with an estimated lethal dose 50% for mice (18–20 g body weight) of 9 μg (450 μg/kg) . This primarily neurotoxic venom provokes progressive paralysis by neuromuscular blockade and, if the inoculum is sufficient, death due to respiratory arrest. The treatment is performed with specific antivenom associated with respiratory support including intensive care in special cases . In this report, we describe the clinical presentation and management of two patients bitten by red-tailed coral snakes, treated at a referral hospital in southwest Colombia.
Between 2005 and 2015, 97 patients were admitted at Fundación Valle del Lili, a tertiary care university hospital in Cali, Colombia, due to snake bites: 12 were bitten by nonvenomous snakes (including non-venomous mimics), 79 by Bothrops and Bothriechis snakes and six (7%) by red-tailed coral snakes (M. mipartitus). Snakes were identified and classified by a biologist based on the dead body that is usually brought by patients. M. mipartitus were classified according to phenotypic characteristics . Although in the geographical area of interest there are other species of Micrurus, there are no records of patients bitten by them during this period. False corals are present in the area and their bites cause minor abrasions. Clinical records of these six patients afflicted by red-tailed coral snake bites were reviewed: three were asymptomatic (had no neurological signs of envenomation, possibly due to dry bites) and three suffered envenomation with neurological involvement. Herein, we describe the clinical characteristics and treatment of the two representative cases. The patients were bitten in the rural area of Jamundí, a city located 24 km away from Cali, Colombia.
A 46-year-old female was accidentally bitten on the outer surface of her left foot by a M. mipartitus snake. The length of the animal could not be measured because its body was fragmented and some parts were lost. The accident occurred in March 31, 2005 at 7:30 a.m. Thirty minutes after the bite she complained of moderate pain and progressive paresthesia in the foot and leg. After that, she developed dysarthria, bilateral palpebral ptosis, difficulty walking and decreased strength in the upper limbs. Two hours after the bite, she was admitted to our hospital.
Eight vials of monovalent coral antivenom (each vial containing 10 mL of equine lyophilized coral antivenom, which neutralizes at least 1 μg of snake venom, manufactured by Laboratorios Probiol SA, Colombia) were administered. No adverse reaction was observed. Six hours after antivenom therapy, the blood gases (PO2 62 mmHg, PaCO2 40 mmHg and pH 7.41), respiratory parameters and neurological examination were all normal, and the patient was extubated (Fig. 2b). She remained hospitalized for 24 additional hours for clinical observation, after which she was discharged asymptomatic, with a normal physical examination.
On October 8, 2010 at 8:30 a.m., a 22-year-old male soldier was accidentally bitten by a red-tailed coral snake of 72 cm in length at the first interdigital space of his right hand. Thirty minutes after the bite he referred mild pain and paresthesia on the right hand. Subsequently, he developed dysarthria and bilateral palpebral ptosis. Three hours after the bite he presented difficulty walking and progressive respiratory distress. Military physicians started bag-mask ventilation, and the patient was transported by helicopter to our hospital. On physical examination, blood pressure was 120/75 mmHg and pulse was 94 beats/min. Neurologic examination demonstrated bilateral palpebral ptosis and flaccid quadriparesis. Cardiopulmonary examination revealed diminished chest expansion. A puncture wound on the first interdigital area of right hand was present, with no edema or signs of bleeding. Full blood count, erythrocyte sedimentation rate, C-reactive protein, coagulation, renal and hepatic function tests were normal. Blood gases showed hypoxemia and moderate hypercapnia (PO2 40 mmHg, PaCO2 50 mmHg).
The patient was then intubated and respiratory support was administered. Six vials of monovalent antivenom (each vial containing 10 mL of equine lyophilized coral antivenom, which neutralizes at least 1 μg of snake venom, manufactured by Laboratorios Probiol SA, Colombia) were applied. The patient had progressive improvement of respiratory parameters, neurological examination and blood gases; therefore extubation was decided 20 h after the admission. He was discharged from hospital 24 h later.
Envenomation by M. mipartitus provokes paralysis due to the neuromuscular blockage of nicotinic acetylcholine receptors elicited by an α-neurotoxin member of the three-finger toxin superfamily . A component of this venom is called mipartoxin-I, which presents the characteristic cysteine signature and amino acid sequence length of the short-chain type-I α-neurotoxins [8, 9]. Mipartoxin-I has shown a potent lethal effect on mice (intraperitoneal median lethal dose: 0.06 μg/g body weight), and causes a strong neuromuscular blockade on both avian and mouse nerve-muscle preparations, presenting a post-synaptic action through the cholinergic nicotinic receptor. M. mipartitus venom provokes a concentration dependent inhibition (3–10 μg/mL) of nerve-mediated twitches and significantly inhibits contractile responses to exogenous ACh (1 mM), but not to KCl (40 mM), which indicates a postsynaptic mechanism of action .
Since mipartoxin-I is the most abundant (28%) protein in M. mipartitus venom, it has been postulated that it should play a major role in its toxicity . Anticholinesterase agents such as neostigmine have proven to reverse the effects of M. frontalis venom on animal model and may be useful in the treatment of some patients . These agents were not employed in the treatment of M. mipartitus envenomation of the present report.
Clinical manifestations of envenoming by M. mipartitus in two patients
Gender, age, bite site
Phase 1 – Initial manifestations
Phase 2 – Neurological symptoms and signs before respiratory arrest – Treatment
Phase 3 – Neurological symptoms and signs after respiratory arrest with patient with respiratory assistance
Case 1, female, 46 y.o., left foot
Onset: 30 min. after the bite, moderate local pain and paresthesia
Onset: One hour after the bite, she shows dysarthria and bilateral palpebral ptosis
Two hours after the bite: difficulty walking and decreased strength in the upper limbs
Three hours after the bite: severe difficulty speaking and progressive respiratory depression – respiratory support and antivenom
Progressive recovery. Extubation: six hours after the antivenom application
Case 2 male, 22 y.o., right hand
Onset: 30 min. after the bite, local pain and paresthesia
Onset: Two hours after the bite, he developed dysarthria and bilateral palpebral ptosis
Three hours after the bite: he presented difficulty walking and progressive respiratory distress – respiratory support and antivenom
Progressive recovery. Extubation: 20 h after the antivenom application
Cases of envenomation by M. mipartitus from Colombia had been previously reported. In 1987, Angel-Mejia R.  described three cases from the northeastern region of the country. The first victim was a 5-year-old girl with mild envenomation that recovered without respiratory support. The second was a woman of 27 years old who had a severe envenomation and was admitted to the hospital 15 h after the bite with severe respiratory distress. She was treated with mechanical ventilation and nine vials of Costa Rica antivenom, and presented progressive recovery. The third victim was 50-year-old man treated with mechanical ventilation who did not receive antivenom and recovered after 14 days. An extension of the latter historic case occurred in the city of Manizales in 1968 and was recently reported . Otero-Patiño et al.  and Badillo et al.  reported two additional cases from northwestern and northeastern Colombia, respectively. Herein, we described two new cases of envenomed patients by red-tailed coral snake, illustrating its clinical presentation and outcome with antivenom treatment.
The authors thank Dr. Jairo Osorno and Dr. David Ascher for the valuable review of article.
This work was supported by Fundación Valle del Lili.
CAC wrote the first draft of the manuscript and contributed to the medical observations. FCH and SCV contributed to writing the manuscript and to the biological analysis related to the snakes. All authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Written informed consent was obtained from the patients for publication of this case report and any accompanying images.
Ethics approval and consent to participate
This report was approved by ethic committee of Fundación Valle del Lili for its publication.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Chippaux JP. Epidemiology of envenomations by terrestrial venomous animals in Brazil based on case reporting: from obvious facts to contingencies. J Venom Anim Toxins incl Trop Dis. 2015;21:13. doi:10.1186/s40409-015-0011-1.View ArticlePubMedPubMed CentralGoogle Scholar
- Remuzgo C, Alvarez MP, Rodriguez E, Lazo F, Yarleque A. Micrurus spixii (Peruvian coral snake) venom - preliminary biochemical and enzymatic characterization. J Venom Anim Toxins incl Trop Dis. 2002;8(1):161–7.View ArticleGoogle Scholar
- Otero-Patiño R. Snake Bites in Colombia. Clin Toxinol. 2014;41–2.Google Scholar
- Cañas CA. Mordeduras por serpientes venenosas. Bol Epidemiol Caldas. 1991;5(2).Google Scholar
- Otero-Patiño R. Manual de diagnóstico y tratamiento del accidente ofídico. Editor Univ Antioquia. 1994;37–46.Google Scholar
- Baldé MC, Chippaux JP, Boiro MY, Stock RP, Massougbodji A. Use of antivenoms for the treatment of envenomation by Elapidae snakes in Guinea, Sub-Saharan Africa. J Venom Anim Toxins incl Trop Dis. 2013;19(6):112–7.Google Scholar
- Campbell JA, Lamar W. The Venomous Reptiles of the Western Hemisphere. In: Coral snakes and sea snakes, family elapidae. Volume 1. Ithaca: Cornell University Press; 2004. p. 200–2.Google Scholar
- Rey-Suárez P, Floriano RS, Rostelato-Ferreira S, Saldarriaga-Córdoba M, Núñez V, Rodrigues-Simioni L, et al. Mipartoxin-I, a novel three-finger toxin, is the major neurotoxic component in the venom of the redtail coral snake Micrurus mipartitus (Elapidae). Toxicon. 2012;60(5):851–63.View ArticlePubMedGoogle Scholar
- Renjifo C, Smith EN, Hodgson WC, Renjifo JM, Sanchez A, Acosta R, et al. Neuromuscular activity of the venoms of the Colombian coral snakes Micrurus dissoleucus and Micrurus mipartitus: an evolutionary perspective. Toxicon. 2012;59(1):132–42.View ArticlePubMedGoogle Scholar
- Cañas CA. Tratamiento de la ofidiotoxicosis. In: Cañas CA, Castro F, Castaño RS, editors. Serpientes venenosas: lecciones aprendidas desde Colombia. Cali: Fundación Valle del Lili Editor; 2016. p. 151–64.Google Scholar
- Vital-Brazil O, Vieira RJ. Neostigmine in the treatment of snake accidents caused by Micrurus frontalis: report of two cases. Rev Inst Med Trop S Paulo. 1996;38(1):61–7.View ArticlePubMedGoogle Scholar
- Ocampo-Trujillo B. Caso clínico histórico. Mordedura de serpiente (rabo de ají) en el año de 1968. Viacrucis de un herpetólogo. Rev Colomb Anestesiol. 2016;44(2):161–9.View ArticleGoogle Scholar
- Angel-Mejía R. Serpientes de Colombia: su relación con el hombre. Ediciones especiales del fondo rotatorio de publicaciones. Universidad de Caldas; 1987. p. 161–4.Google Scholar
- Otero-Patiño R, Tobón GS, Gómez LF, Osorio R, Valderrama R, Hoyos R, et al. Accidente ofídico en Antioquia y Chocó. Aspectos clínicos y epidemiológicos (marzo de 1989 - febrero de 1990). Acta Med Colomb. 1992;17(4):229–49.Google Scholar
- Badillo R, Casas M, Gamarra G. Ofidiotoxicosis en el Hospital Universitario Ramón Gonzáles de Bucaramanga. Acta Med Colomb. 1989;14(6):352–68.Google Scholar